247 related articles for article (PubMed ID: 31233736)
1. Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands.
Altinier S; Puthenparampil M; Zaninotto M; Toffanin E; Ruggero S; Gallo P; Plebani M
Clin Chim Acta; 2019 Sep; 496():117-120. PubMed ID: 31233736
[TBL] [Abstract][Full Text] [Related]
2. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
Bayart JL; Muls N; van Pesch V
Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
[TBL] [Abstract][Full Text] [Related]
3. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.
Huss A; Mojib-Yezdani F; Bachhuber F; Fangerau T; Lewerenz J; Otto M; Tumani H; Senel M
Clin Chim Acta; 2019 Nov; 498():148-153. PubMed ID: 31437445
[TBL] [Abstract][Full Text] [Related]
4. Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis.
Agnello L; Lo Sasso B; Salemi G; Altavilla P; Pappalardo EM; Caldarella R; Meli F; Scazzone C; Bivona G; Ciaccio M
Lab Med; 2020 Jul; 51(4):402-407. PubMed ID: 31943078
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
[TBL] [Abstract][Full Text] [Related]
6. Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis.
Dekeyser C; De Kesel P; Cambron M; Vanopdenbosch L; Van Hijfte L; Vercammen M; Laureys G
Front Immunol; 2024; 15():1385231. PubMed ID: 38745673
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
[TBL] [Abstract][Full Text] [Related]
8. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
Hassan-Smith G; Durant L; Tsentemeidou A; Assi LK; Faint JM; Kalra S; Douglas MR; Curnow SJ
J Neuroimmunol; 2014 Nov; 276(1-2):175-9. PubMed ID: 25146968
[TBL] [Abstract][Full Text] [Related]
9. Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis.
Gudowska-Sawczuk M; Tarasiuk J; Kułakowska A; Kochanowicz J; Mroczko B
Brain Sci; 2020 May; 10(6):. PubMed ID: 32471086
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
Gaetani L; Di Carlo M; Brachelente G; Valletta F; Eusebi P; Mancini A; Gentili L; Borrelli A; Calabresi P; Sarchielli P; Ferri C; Villa A; Di Filippo M
J Neuroimmunol; 2020 Feb; 339():577108. PubMed ID: 31743879
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.
Hegen H; Berek K; Deisenhammer F
Wien Med Wochenschr; 2022 Nov; 172(15-16):337-345. PubMed ID: 35133530
[TBL] [Abstract][Full Text] [Related]
12. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
[TBL] [Abstract][Full Text] [Related]
13. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
Beseler C; Vollmer T; Graner M; Yu X
PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
[TBL] [Abstract][Full Text] [Related]
14. Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG.
Zeman D; Hradilek P; Kusnierova P; Piza R; Reguliova K; Woznicova I; Zapletalova O
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):104-13. PubMed ID: 25485529
[TBL] [Abstract][Full Text] [Related]
15. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
[TBL] [Abstract][Full Text] [Related]
16. The elusive nature of the oligoclonal bands in multiple sclerosis.
Kennedy PGE; George W; Yu X
J Neurol; 2024 Jan; 271(1):116-124. PubMed ID: 37945762
[TBL] [Abstract][Full Text] [Related]
17. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.
Duranti F; Pieri M; Centonze D; Buttari F; Bernardini S; Dessi M
J Neuroimmunol; 2013 Oct; 263(1-2):116-20. PubMed ID: 23916392
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.
Christiansen M; Gjelstrup MC; Stilund M; Christensen T; Petersen T; Jon Møller H
Clin Chem Lab Med; 2018 Dec; 57(2):210-220. PubMed ID: 30055097
[TBL] [Abstract][Full Text] [Related]
19. Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.
Mancuso R; Franciotta D; Rovaris M; Caputo D; Sala A; Hernis A; Agostini S; Calvo M; Clerici M
Mult Scler; 2014 Dec; 20(14):1900-3. PubMed ID: 24948690
[TBL] [Abstract][Full Text] [Related]
20. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
